Top new orphan molecular entities by U.S. sales in 2019

This statistic displays a projection of the top orphan molecular entities (approved in 2014) based on projected U.S. consensus sales in 2019. Biogen's Eloctate was approved in June 2014 and generated 58 million U.S. dollars in revenue during the same year in the United States. Orphan drugs are used to target rare diseases or disorders, which in the United States is defined as less than 200,000 patients. The development of orphan drugs are currently incentivized in the United States through the Orphan Drug Act of 1983.

Leading new orphan molecular entities by U.S. sales in 2014 and 2019 (in million U.S. dollars)*

20142019
---
---
---
---
---
---
---
---
---
---
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

October 2015

Region

United States

Survey time period

2014 and 2015

Supplementary notes

* Products approved during 2014; ranked based on U.S. consensus sales in 2019 (projected).

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical industry in the Netherlands"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.